Protalix BioTherapeutics (PLX) Change in Inventory (2010 - 2026)
Protalix BioTherapeutics' quarterly Change in Inventory came in at $4.7 million in Q1 2026, up 373.17% year-on-year from $1.0 million in Q1 2025, and up 6.06% quarter-over-quarter from $4.5 million in Q4 2025.
Protalix BioTherapeutics has reported Change in Inventory for 17 years, with the latest figure at $4.7 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Inventory rose 373.17% year-over-year to $4.7 million; the trailing twelve-month figure through Mar 2026 stood at $11.0 million (up 486.2% YoY), and the FY2025 full-year result was $4.5 million, up 104.09% from the prior year.
- Change in Inventory for Q1 2026 stood at $4.7 million, up from $4.5 million in the prior quarter.
- The five-year high for Change in Inventory was $4.7 million in Q1 2026, with the low at -$3.5 million in Q3 2024.
- Average Change in Inventory over 5 years is $736470.6, with a median of $124000.0 recorded in 2025.
- Year-over-year, Change in Inventory sank 667.82% in 2023 and soared 373.17% in 2026.
- Tracing PLX's Change in Inventory over 5 years: stood at $2.2 million in 2022, then slumped by 213.2% to -$2.5 million in 2023, then surged by 259.34% to $4.0 million in 2024, then rose by 10.63% to $4.5 million in 2025, then grew by 6.06% to $4.7 million in 2026.
- The last three Change in Inventory figures came in at $4.7 million (Q1 2026), $4.5 million (Q4 2025), and $124000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 665.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 97.70 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -26.60 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 3.32 Mn |
| 10 | Protalix BioTherapeutics | 164.49 Mn | 153.70 Mn | 29.62 Mn | 4.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.75 Mn |
| Mar 31, 2026 | 4.75 Mn |
| Dec 31, 2025 | 4.47 Mn |
| Dec 31, 2025 | 4.47 Mn |
| Sep 30, 2025 | 124,000.00 |
| Sep 30, 2025 | 124,000.00 |
| Jun 30, 2025 | 1.63 Mn |
| Jun 30, 2025 | 1.63 Mn |
| Mar 31, 2025 | -1.74 Mn |
| Mar 31, 2025 | -1.74 Mn |
| Dec 31, 2024 | 4.04 Mn |
| Dec 31, 2024 | 4.04 Mn |
| Sep 30, 2024 | -3.52 Mn |
| Sep 30, 2024 | -3.52 Mn |
| Jun 30, 2024 | -1.63 Mn |
| Jun 30, 2024 | -1.63 Mn |
| Mar 31, 2024 | 3.30 Mn |
| Mar 31, 2024 | 3.30 Mn |
| Dec 31, 2023 | -2.54 Mn |
| Dec 31, 2023 | -2.54 Mn |
| Sep 30, 2023 | 1.95 Mn |
| Sep 30, 2023 | 1.95 Mn |
| Jun 30, 2023 | -668,000.00 |
| Jun 30, 2023 | -668,000.00 |
| Mar 31, 2023 | 3.50 Mn |
| Mar 31, 2023 | 3.50 Mn |
| Dec 31, 2022 | 2.24 Mn |
| Dec 31, 2022 | 2.24 Mn |
| Sep 30, 2022 | -1.95 Mn |
| Sep 30, 2022 | -1.95 Mn |
| Jun 30, 2022 | -87,000.00 |
| Jun 30, 2022 | -87,000.00 |
| Mar 31, 2022 | -1.36 Mn |
| Mar 31, 2022 | -1.36 Mn |
| Dec 31, 2021 | 3.22 Mn |
| Dec 31, 2021 | 3.22 Mn |
| Sep 30, 2021 | 1.09 Mn |
| Sep 30, 2021 | 1.09 Mn |
| Jun 30, 2021 | -275,000.00 |
| Jun 30, 2021 | -275,000.00 |
| Mar 31, 2021 | 833,000.00 |
| Mar 31, 2021 | 833,000.00 |
| Dec 31, 2020 | -199,000.00 |
| Dec 31, 2020 | -199,000.00 |
| Sep 30, 2020 | 2.22 Mn |
| Sep 30, 2020 | 2.22 Mn |
| Jun 30, 2020 | 1.58 Mn |
| Jun 30, 2020 | 1.58 Mn |
| Mar 31, 2020 | 1.33 Mn |
| Mar 31, 2020 | 1.33 Mn |
| Dec 31, 2019 | 630,000.00 |
| Dec 31, 2019 | 630,000.00 |
| Sep 30, 2019 | 527,000.00 |
| Sep 30, 2019 | 527,000.00 |
| Jun 30, 2019 | 291,000.00 |
| Jun 30, 2019 | 291,000.00 |
| Mar 31, 2019 | -1.86 Mn |
| Mar 31, 2019 | -1.86 Mn |
| Dec 31, 2018 | 610,000.00 |
| Dec 31, 2018 | 610,000.00 |
| Sep 30, 2018 | 981,000.00 |
| Sep 30, 2018 | 981,000.00 |
| Jun 30, 2018 | -41,000.00 |
| Jun 30, 2018 | -41,000.00 |
| Mar 31, 2018 | -814,000.00 |
| Mar 31, 2018 | -814,000.00 |
| Dec 31, 2017 | 354,000.00 |
| Dec 31, 2017 | 354,000.00 |
| Sep 30, 2017 | 420,000.00 |
| Sep 30, 2017 | 420,000.00 |
| Jun 30, 2017 | -41,000.00 |
| Jun 30, 2017 | -41,000.00 |
| Mar 31, 2017 | 1.86 Mn |
| Mar 31, 2017 | 1.86 Mn |
| Dec 31, 2016 | 385,000.00 |
| Dec 31, 2016 | 385,000.00 |
| Sep 30, 2016 | -1.21 Mn |
| Sep 30, 2016 | -1.21 Mn |
| Jun 30, 2016 | 330,000.00 |
| Jun 30, 2016 | 330,000.00 |
| Mar 31, 2016 | -30,000.00 |
| Mar 31, 2016 | -30,000.00 |
| Dec 31, 2015 | 2.40 Mn |
| Dec 31, 2015 | 2.40 Mn |
| Sep 30, 2015 | 253,000.00 |
| Sep 30, 2015 | 253,000.00 |
| Jun 30, 2015 | -319,000.00 |
| Jun 30, 2015 | -319,000.00 |
| Mar 31, 2015 | -16,000.00 |
| Mar 31, 2015 | -16,000.00 |
| Mar 31, 2014 | -1.43 Mn |
| Mar 31, 2014 | -1.43 Mn |
| Dec 31, 2013 | 380,000.00 |
| Dec 31, 2013 | 380,000.00 |
| Sep 30, 2013 | 386,000.00 |
| Sep 30, 2013 | 386,000.00 |
| Jun 30, 2013 | 1.42 Mn |
| Jun 30, 2013 | 1.42 Mn |
| Mar 31, 2013 | 1.73 Mn |
| Mar 31, 2013 | 1.73 Mn |
| Dec 31, 2012 | 1.98 Mn |
| Dec 31, 2012 | 1.98 Mn |
| Sep 30, 2012 | 1.03 Mn |
| Sep 30, 2012 | 1.03 Mn |
| Jun 30, 2012 | 766,000.00 |
| Jun 30, 2012 | 766,000.00 |
| Mar 31, 2012 | -16,000.00 |
| Mar 31, 2012 | -16,000.00 |
| Dec 31, 2011 | -148,000.00 |
| Dec 31, 2011 | -148,000.00 |
| Sep 30, 2011 | -110,000.00 |
| Sep 30, 2011 | -110,000.00 |
| Jun 30, 2011 | -564,000.00 |
| Jun 30, 2011 | -564,000.00 |
| Mar 31, 2011 | -88,000.00 |
| Mar 31, 2011 | -88,000.00 |
| Dec 31, 2010 | -5.51 Mn |
| Dec 31, 2010 | -5.51 Mn |
| Sep 30, 2010 | 6.70 Mn |
| Sep 30, 2010 | 6.70 Mn |